In this issue, Handelsman (doi: 10.5694/mja11.11277) describes changes in the patterns of testosterone prescribing in Australia from 1992 to 2010. He reports that there has been at least a twofold increase in total expenditure on prescriptions, taking into account inflation and population growth, and the increase in expenditure is greater than the increase in prescribing. Yet, there has been no change in the approved indications for the use of testosterone (androgen deficiency due to disorders of the hypothalamic–pituitary–testicular axis) or in the frequency of the conditions for which it is approved.
- 1. Payer L. Disease-mongers: how doctors, drug companies, and insurers are making you feel sick. New York: Wiley and Sons, 1992: 292.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.